OXYCODONE DIN 02325969
Health Canada record
| Active ingredient(s) | OXYCODONE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N02AA05 OXYCODONE |
| Original market date | 10-Jun-2009 |
| Current status date | 01-Nov-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXYCODONE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02306530 | APO-OXYCODONE CR | APOTEX INC | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Marketed |
| 02324628 | APO-OXYCODONE/ACET | APOTEX INC | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02231934 | OXY.IR | PURDUE PHARMA | Tablet | OXYCODONE HYDROCHLORIDE 5 MG | Marketed |
| 02240132 | OXY.IR | PURDUE PHARMA | Tablet (Immediate-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Marketed |
| 02240131 | OXY.IR | PURDUE PHARMA | Tablet | OXYCODONE HYDROCHLORIDE 10 MG | Marketed |
| 02319993 | PMS-OXYCODONE | PHARMASCIENCE INC | Tablet | OXYCODONE HYDROCHLORIDE 20 MG | Marketed |
| 02319985 | PMS-OXYCODONE | PHARMASCIENCE INC | Tablet | OXYCODONE HYDROCHLORIDE 10 MG | Marketed |
| 02319977 | PMS-OXYCODONE | PHARMASCIENCE INC | Tablet | OXYCODONE HYDROCHLORIDE 5 MG | Marketed |
| 02309904 | PMS-OXYCODONE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Marketed |
| 02309912 | PMS-OXYCODONE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 80 MG | Marketed |
| 02309882 | PMS-OXYCODONE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG | Marketed |
| 02309890 | PMS-OXYCODONE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Marketed |
| 02242468 | RIVACOCET | LABORATOIRE RIVA INC. | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 00443948 | SUPEUDOL 10 | SANDOZ CANADA INCORPORATED | Tablet | OXYCODONE HYDROCHLORIDE 10 MG | Marketed |
| 02262983 | SUPEUDOL 20 | SANDOZ CANADA INCORPORATED | Tablet | OXYCODONE HYDROCHLORIDE 20 MG | Marketed |
| 00789739 | SUPEUDOL 5 | SANDOZ CANADA INCORPORATED | Tablet | OXYCODONE HYDROCHLORIDE 5 MG | Marketed |
| 02339625 | TARGIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG; NALOXONE HYDROCHLORIDE 20 MG | Marketed |
| 02339609 | TARGIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG; NALOXONE HYDROCHLORIDE 5 MG | Marketed |
| 02339617 | TARGIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG; NALOXONE HYDROCHLORIDE 10 MG | Marketed |
| 00608165 | TEVA-OXYCOCET | TEVA CANADA LIMITED | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 00608157 | TEVA-OXYCODAN | TEVA CANADA LIMITED | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETYLSALICYLIC ACID 325 MG | Marketed |
| 01916548 | ENDOCET | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 01916483 | ENDODAN | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETYLSALICYLIC ACID 325 MG | Cancelled Post Market |
| 02346141 | NTP-OXYCODONE ACETAMINOPHEN | NT PHARMA CANADA LTD | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Pre Market |
| 02336391 | NU-OXYCODONE/ACET | NU-PHARM INC | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled (Unreturned Annual) |
| 02325950 | OXYCODONE | PRO DOC LIMITEE | Tablet | OXYCODONE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02325977 | OXYCODONE | PRO DOC LIMITEE | Tablet | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02327171 | OXYCODONE-ACET | PRO DOC LIMITEE | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02361361 | OXYCODONE/ACET | SANIS HEALTH INC | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02359774 | OXYCODONE/ACETAMINOPHEN | NT PHARMA CANADA LTD | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Pre Market |
| 02323206 | OXYCONTIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 02323214 | OXYCONTIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 60 MG | Cancelled Post Market |
| 02323192 | OXYCONTIN | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 02202441 | OXYCONTIN 10MG | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02202468 | OXYCONTIN 20MG | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02202476 | OXYCONTIN 40MG | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Cancelled Post Market |
| 02258129 | OXYCONTIN 5MG | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02202484 | OXYCONTIN 80MG | PURDUE PHARMA | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 80 MG | Cancelled Post Market |
| 01916475 | PERCOCET | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 01916491 | PERCOCET-DEMI | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 2.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 01916572 | PERCODAN | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETYLSALICYLIC ACID 325 MG | Cancelled Post Market |
| 01916556 | PERCODAN-DEMI | BRISTOL-MYERS SQUIBB CANADA | Tablet | OXYCODONE HYDROCHLORIDE 2.5 MG; ACETYLSALICYLIC ACID 325 MG | Cancelled Post Market |
| 02245758 | PMS-OXYCODONE - ACETAMINOPHEN | PHARMASCIENCE INC | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02341034 | RIVA-OXYCODONE CR | LABORATOIRE RIVA INC. | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02341069 | RIVA-OXYCODONE CR | LABORATOIRE RIVA INC. | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 80 MG | Cancelled Pre Market |
| 02341050 | RIVA-OXYCODONE CR | LABORATOIRE RIVA INC. | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Cancelled Pre Market |
| 02341042 | RIVA-OXYCODONE CR | LABORATOIRE RIVA INC. | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Pre Market |
| 02242395 | RIVACODAN | LABORATOIRE RIVA INC. | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETYLSALICYLIC ACID 325 MG | Cancelled Pre Market |
| 01916327 | ROXICET TAB | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02326299 | SANDOZ OXYCODONE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 80 MG | Cancelled Pre Market |
| 02326280 | SANDOZ OXYCODONE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Cancelled Pre Market |
| 02326272 | SANDOZ OXYCODONE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Pre Market |
| 02326264 | SANDOZ OXYCODONE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02307898 | SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Tablet | OXYCODONE HYDROCHLORIDE 5 MG; ACETAMINOPHEN 325 MG | Dormant |
| 00392480 | SUPEUDOL 10 | SANDOZ CANADA INCORPORATED | Suppository | OXYCODONE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00392472 | SUPEUDOL 20 | SANDOZ CANADA INCORPORATED | Suppository | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02285037 | TEVA-OXYCODONE CR | TEVA CANADA LIMITED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02285045 | TEVA-OXYCODONE CR | TEVA CANADA LIMITED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 20 MG | Cancelled Pre Market |
| 02291266 | TEVA-OXYCODONE CR | TEVA CANADA LIMITED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 40 MG | Cancelled Pre Market |
| 02291274 | TEVA-OXYCODONE CR | TEVA CANADA LIMITED | Tablet (Extended-Release) | OXYCODONE HYDROCHLORIDE 80 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10197 | 2009-05-07 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |
International API supply for OXYCODONE HYDROCHLORIDE
8 valid EDQM Certificates of Suitability from 7 holders. 6 active FDA Drug Master Files.
Request a quote for OXYCODONE